When Donald Trump returned to the White House after a brief spell in hospital with Covid-19 last October he made a video attributing his rapid recovery to a drug he called ‘Regeneron’. ‘They call it a therapeutic drug, but to me it wasn’t therapeutic – it made me better,’ he said. ‘I call that a cure.’
Naturally, given that Trump had on a previous occasion appeared to advocate injecting humans with disinfectant, there was an element of scepticism on the part of many viewers. However, the drug he was talking about went on the receive emergency use authorisation in November from the US Food and Drug Administration. We now have interim results from a Phase 3 trial in which the drug was used as a ‘passive vaccine’.
Regeneron is actually the name of the company; the drug itself is called Regen-Cov.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in